7 Questions on US Benzodiazepine & Opioid Prescribing Trends

February 7, 2020
Sydney Jennings

Associate Editor of Patient Care Online

Sample: Approximately what percentage of physician office visits at which benzodiazepines were coprescribed with opioids were with a primary care provider?

Coprescribing benzodiazepines and opioids is not recommended because it can increase a patient's risk of respiratory depression, however, a 2019 trend analysis that used data from the National Ambulatory Medical Care Survey (NAMCS) found that in 2015 alone, opioids were prescribed at 26.4% of physician office visits at which there was also a benzodiazepine prescription. To evaluate the characteristics of office-based physician visits where benzodiazepines are prescribed as well as visits that involve overlapping opioid prescriptions in the US, the Centers for Disease Control and Prevention recently released a National Health Statistics Report that examined data from the 2014-2016 NAMCS. Answer the 7 questions below based on the National Health Statistics Report to learn more about the prescribing trends of benzodiazepines as well as coprescribing trends of benzodiazepines and opioids in the US.

Related Content:

Pain